Dopaminergic agents and nutritional status in Parkinson's disease

Mov Disord. 2014 Oct;29(12):1543-7. doi: 10.1002/mds.25991. Epub 2014 Sep 12.

Abstract

Background: Malnutrition has been found in up to 24% of patients with Parkinson's disease; dopaminergic drugs might impair nutritional status. We evaluated the association of nutritional status with the use of dopaminergic agents.

Methods: We analyzed data from 75 elderly patients with Parkinson's disease attending a geriatric day hospital. Nutritional status was assessed by the Mini Nutritional Assessment (MNA). Dopaminergic drugs were normalized for weight.

Results: In linear regression, total levodopa (l-dopa) equivalent daily dose (LEDD) was associated with worse MNA (B = -0.14, 95% CI = -0.26--0.02; P = 0.019). This association remained significant only for l-dopa (B = -0.19, 95% CI = -0.32--0.52; P = 0.007), but not dopaminergic agent dosages. Increasing l-dopa dosages were associated with increasing probability of risk of malnutrition (P for trend = 0.049).

Conclusions: In our population, LEDD was associated with worse nutritional status and risk of malnutrition; this association was limited to use of l-dopa.

Keywords: Parkinson's disease; dopaminergic drugs; epidemiology; levodopa; nutritional status.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Dopamine Agents / adverse effects*
  • Female
  • Humans
  • Levodopa / adverse effects*
  • Levodopa / therapeutic use*
  • Male
  • Malnutrition / chemically induced*
  • Middle Aged
  • Nutritional Status / drug effects
  • Nutritional Status / physiology*
  • Parkinson Disease / drug therapy*

Substances

  • Dopamine Agents
  • Levodopa